Abstract:In 2013, 15 clusters of mumps were notified in France; 72% (82/114) of the cases had been vaccinated twice with measles-mumps-rubella vaccine. To determine whether the risk of mumps increased with time since the last vaccination, we conducted a case-control study among clusters in universities and military barracks. A confirmed case had an inflammation of a salivary gland plus laboratory confirmation in 2013. A probable case presented with inflammation of a salivary gland in 2013 either lasting for > 2 days or… Show more
“…Mumps immunity has also been shown to wane with time after vaccination [31,32]. However, our study found absence of mumps antibodies in all four age groups.…”
Section: Discussioncontrasting
confidence: 63%
“…However, our study found absence of mumps antibodies in all four age groups. In order to better prepare for future outbreaks, booster doses of MMR may be needed in vaccination programs, especially for the younger age groups whose immunity is induced by vaccination [31].…”
“…Mumps immunity has also been shown to wane with time after vaccination [31,32]. However, our study found absence of mumps antibodies in all four age groups.…”
Section: Discussioncontrasting
confidence: 63%
“…However, our study found absence of mumps antibodies in all four age groups. In order to better prepare for future outbreaks, booster doses of MMR may be needed in vaccination programs, especially for the younger age groups whose immunity is induced by vaccination [31].…”
“…Most cases occurred on college and university campuses among young adults, nearly all of whom had been vaccinated during early childhood (9). Data from outbreak studies showed that the odds of developing mumps increased by 10 to 27% with each year postvaccination, suggesting waning immunity as the basis for these outbreaks (10,75). This observation was consistent with data from other studies that showed that mumps virus-neutralizing Ab titers declined significantly with time postvaccination (76,77), although the level of Ab that confers protection was not known.…”
Since the middle of the 20th century, vaccines have made a significant public health impact by controlling infectious diseases globally. Although long-term protection has been achieved with some vaccines, immunity wanes over time with others, resulting in outbreaks or epidemics of infectious diseases. Long-term protection against infectious agents that have a complex life cycle and antigenic variation remains a key challenge. Novel strategies to characterize the short-and long-term immune responses to vaccines and to induce immune responses that mimic natural infection have recently emerged. New technologies and approaches in vaccinology, such as adjuvants, delivery systems, and antigen formulations, have the potential to elicit more durable protection and fewer adverse reactions; together with in vitro systems, these technologies have the capacity to model and accelerate vaccine development. The National Institute of Allergy and Infectious Diseases (NIAID) held a workshop on 19 September 2016 that focused on waning immunity to selected vaccines (for Bordetella pertussis, Salmonella enterica serovar Typhi, Neisseria meningitidis, influenza, mumps, and malaria), with an emphasis on identifying knowledge gaps, future research needs, and how this information can inform development of more effective vaccines for infectious diseases.
“…However, mumps outbreaks have occurred in the United States in the last decade, including the large outbreak centered around a university in Iowa, which had over 5,000 cases in 2006 [36–39]. Mumps outbreaks have also been reported in vaccinated populations in Europe and Asia [20–23,40,41]. None of these outbreaks were associated with a genotype A MuV, which was the Jeryl Lynn vaccine genotype.…”
Section: Discussionmentioning
confidence: 99%
“…It is possible that this decrease may contribute to some of the recent outbreaks. It has been shown that there is variation in serum neutralizing antibodies among people over time [21,41–43]. Poor immune responses or waning immunity may result in some individuals dropping below a protective threshold.…”
Mumps virus (MuV) causes acute infection in humans with characteristic swelling of the parotid gland. While vaccination has greatly reduced the incidence of MuV infection, there have been multiple large outbreaks of mumps virus (MuV) in highly vaccinated populations. The most common vaccine strain, Jeryl Lynn, belongs to genotype A, which is no longer a circulating genotype. We have developed two vaccine candidates that match the circulating genotypes in the United States (genotype G) and China (genotype F). We found that there was a significant decrease in the ability of the Jeryl Lynn vaccine to produce neutralizing antibody responses to non-matched viruses, when compared to either of our vaccine candidates. Our data suggests that an updated vaccine may allow for better immunity against the circulating MuV genotypes G and F.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.